Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 18/20 | 0.42 |
| ▸ | ALOX5AP | P20292 | 17/20 | 0.42 |
| ▸ | FYN | P06241 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29686449 | 1.00 | FEN1 (0.42) | FEN1ALOX5APFYN | |
| SCHEMBL24498204 | 0.82 | ALOX5AP (0.42) | FEN1ALOX5APFYN | |
| SCHEMBL29686853 | 0.82 | ALOX5AP (0.42) | FEN1ALOX5APFYN | |
| SCHEMBL26512731 | 0.82 | ALOX5AP (0.35) | FEN1ALOX5AP | |
| SCHEMBL28838931 | 0.79 | ALOX5AP (0.34) | FEN1ALOX5AP | |
| SCHEMBL30740055 | 0.78 | FEN1 (0.45) | FEN1ALOX5AP | |
| SCHEMBL27172758 | 0.78 | FEN1 (0.45) | FEN1ALOX5AP | |
| SCHEMBL24498032 | 0.78 | FEN1 (0.44) | FEN1ALOX5AP | |
| SCHEMBL29686208 | 0.78 | FEN1 (0.44) | FEN1ALOX5AP | |
| SCHEMBL26119323 | 0.77 | TYK2 (0.34) | FEN1ALOX5AP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101548-A1 | HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD (CN) | 2024-03-28 | — | — | US | disclosed |
| EP-4257587-A1 | HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shenzhen Chipscreen Biosciences Co., Ltd. (CN) | 2023-10-11 | — | — | EP | disclosed |
| WO-2022117016-A1 | HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 深圳微芯生物科技股份有限公司 | 2022-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240101548-A1 | HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | TYK2, WEE2, WEE1 | FEN1 3616/4885ALOX5AP 1962/4885FYN 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.